Impact of age on clinical risk scores in follicular lymphoma by Stefan Alig, Vindi Jurinovic, Alessandro Pastore, Sarah Haebe, Christian Schmidt, Anna-Katharina Zoellner, Martin Dreyling, Michael Unterhalt, Eva Hoster, Wolfgang Hiddemann, and Oliver Weigert BloodAdv Volume 3(7):1033-1038 April 9, 2019 © 2019 by The American Society of Hematology

Stefan Alig et al. Blood Adv 2019;3:1033-1038 © 2019 by The American Society of Hematology

Flow diagram of patient selection. Stefan Alig et al. Blood Adv 2019;3:1033-1038 © 2019 by The American Society of Hematology

PFS according to PRIMA-PI, FLIPI, and FLIPI-2. PFS according to PRIMA-PI, FLIPI, and FLIPI-2. Kaplan-Meier curves showing PFS of risk cohorts defined by the 3 scores. Log-rank P values are shown in the graph. Sizes and relations of high-risk cohorts identified by the 3 scores are shown by a scaled Venn diagram (only patients evaluable for all scores). int., intermediate. Stefan Alig et al. Blood Adv 2019;3:1033-1038 © 2019 by The American Society of Hematology

PFS according to the PRIMA-PI, FLIPI, and FLIPI-2 by age. PFS according to the PRIMA-PI, FLIPI, and FLIPI-2 by age. Kaplan-Meier curves showing PFS of risk cohorts defined by the 3 scores for patients ≤60 years (left) and >60 years (right). Log-rank P values are shown in the graph. Sizes and relations of high-risk cohorts identified by the 3 scores are shown by a scaled Venn diagram (only patients evaluable for all scores). Stefan Alig et al. Blood Adv 2019;3:1033-1038 © 2019 by The American Society of Hematology